AU2019200301A1 — Novel methods
Assigned to Intra Cellular Therapies Inc · Expires 2019-02-07 · 7y expired
What this patent protects
A long-acting injectable composition comprising polymeric microspheres comprising a PLGA matrix with either carboxylic acid or carboxylic ester end groups, and an effective amount of a 5 Compound of Formula I, the Compound of Formula I being dispersed, dissolved or encapsulated i…
USPTO Abstract
A long-acting injectable composition comprising polymeric microspheres comprising a PLGA matrix with either carboxylic acid or carboxylic ester end groups, and an effective amount of a 5 Compound of Formula I, the Compound of Formula I being dispersed, dissolved or encapsulated in the polymer matrix of the microsphere: HN - Y~a Formula I wherein: X is -0-, -NH- or -N(CH3)-; 10 Y is -0-, -C(R2)(OH)-, -C(R3)(OR1) or -C(O)-; R1 is -C1. 6 alkyl or -C(O)-Ci-21alkyl optionally saturated or unsaturated and optionally substituted with one or more hydroxy or Ci-22alkoxy groups, wherein such compound hydrolyzes to form the residue of a natural or unnatural, saturated or unsaturated fatty acid; 15 R2 is H or -CI.6alkyl; and R3 is H or -CI.6alkyl; in free or pharmaceutically acceptable salt form.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.